Telemedicine and Nursing Home

Elderly Clinical Trial

— GERONTACCESS  

Official title:

Impact of Telemedicine on Avoiding Emergency Hospital Admissions and Hospitalization for Nursing Home Residents

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02816177
• Other study ID #: I14036/GERONTACCESS
• Status: Completed
• Phase: N/A
• Start date: July 5, 2016
• Est. completion date: June 2019

Study information

• Verified date: January 2019
• Source: University Hospital, Limoges
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Telemedicine-based care provides remote health and social care to maintain people's autonomy and increase their quality of life. The rapidly aging population has come with a significant increase in the prevalence of chronic diseases and their effects, and thus the need for increased care and welfare.

This solutions give a new opportunity for diagnosis, treatment, education, and rehabilitation, and make it possible to monitor patients with a number of chronic diseases. It also reduces socioeconomic disparity with regard to access to care and gives equal chances to patients from urban and rural areas.

This a randomized trial of telemedicine versus usual care alone to reduce hospitalization and emergency hospital admissions for Nursing Home Residents .

After an initial assessment , each participant is monitored by teleconsultation on six occasions over 12 months. Patients with usual care have an initial and a 12 months assessments.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 428
• Est. completion date: June 2019
• Est. primary completion date: January 18, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

• Elderly over 60 years

• Resident in nursing homes

• Resident with multiples chronic diseases with at least two comorbidities

• Having given free and informed consent in writing and signed by himself and / or his legal representative

Exclusion Criteria:

• Resident unaffiliated or not beneficiary of Social Security

• Resident with a life-threatening disease

Related Conditions & MeSH terms

• Elderly
• Multimorbidity

Intervention

Other:
• Telemedicine

• Usual Care

Locations

Country	Name	City	State
France	Service de Gériatrie	Limoges

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Limoges

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Efficacy	Proportion of patients who had an admission to the emergency or unscheduled hospitalization in health service or surgery	12 month
Secondary	MAST	Cost / effectiveness of telemedicine based on the MAST model (Model of Assessment of Telemedicine ).	12 months